A talk by Dr Adele Hosseini B.Pharm, M.Pharm, PhD
Chief Scientific Officer,
Bod Australia
About this talk
In this presentation, Dr. Hosseini details the clinic applications of a specific CBD-dominant medicine based on validated phase-IV research on the use of the medicine in practice. In-depth discussion on specific patient case studies dosage and patient specific outcomes. The importance of quality, cannabinoid consistency, and source are also discussed in relation to the role in patient care and relevance to medicine assessment.
Categories covered by this talk
Dr Adele Hosseini B.Pharm, M.Pharm, PhD
Dr. Adele Hosseini, Chief Scientific Officer for Bod Australia, is pioneering into medicinal cannabis for commercialisation.
Proudly supported by
Want to sponsor this event? contact us.